Future work using in vivo models of atherosclerosis with SMC-specific TWIST1 overexpression or knockdown will be important for better understanding how TWIST1 alters expression of its downstream targets and contributes to lesion burden in the complex atherosclerosis environment. The gene discussed is TWIST1; the disease is atherosclerosis.